En español
NIDA

Menu

A Baseline for Investigating Diffusion of Innovation

The "Baseline Study" was designed to help us better understand the Community Treatment Programs participating in the NIDA Clinical Trials Network (CTN). Using a series of surveys, the study sought to 1) describe the programs and practitioners delivering drug abuse treatment services within the CTN; 2) build a system that can track changes in program and staff characteristics; 3) allow treatment program managers to compare their program to others both within the CTN and nationwide; and 4)promote studies of organizational change and the characteristics that predict whether research-based treatment strategies will become part of usual treatment in a program.

CTN Protocol ID: 
CTN-0008
DSMB ID: 
DSMB-0008
Enrollment Status: 
Completed
Primary Outcomes Article: 

McCarty, D., et al. (2008).  Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.  Drug & Alcohol Dependence 92:200-207. 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223274/

Principal Investigator(s)
Dennis McCarty, Ph.D.
Professor
Oregon Health & Science University
Department of Public Health and Preventive Medicine
3181 S.W. Sam Jackson Park Rd.
CB 669
Portland, OR 97239
mccartyd@ohsu.edu

    Attention

    Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.

    Helpline open during government shutdown

    Featured Publication

    Featured Publication

    Drugs, Brains, and Behavior - The Science of Addiction

    As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.